Nephrology
News
Albuminuria reduction fuels finerenone’s kidney benefits
Mediation analyses of finerenone trial data show most of the drug’s kidney benefit and a third of its CVD benefit comes from cutting albuminuria...
News
T2D: Real benefits of new oral antidiabetic drugs
What about in the real world? Could combining SGLT2 inhibitors with GLP-1R agonists be even more effective?
Conference Coverage
Blood pressure lowering reduces dementia risk
“This proven, effective intervention should be widely scaled up to reduce the global burden of dementia.”
News
Risk calculator for early-stage CKD may soon enter U.S. market
Klinrisk, which estimates an adult’s risk for CKD progression from 20 lab values, may spur more targeted, intensified treatment.
Conference Coverage
Aprocitentan reduces resistant hypertension in CKD
Aprocitentan, a novel dual endothelin antagonist, showed antihypertensive efficacy and manageable safety in people with chronic kidney disease.
News
EMR prompt boosts albuminuria measurement in T2D
An EMR prompt in primary care to measure albuminuria and eGFR in adults with type 2 diabetes boosted screening by about 50%.
Conference Coverage
New calculator tool estimates fracture risk on dialysis
Calculator uses readily available clinical factors and will soon be freely accessible.
News
CKD linked to cardiac arrest in Hispanic, Latinx patients
“Our study, the first to include feasible numbers of Hispanic or Latino individuals, highlights the importance of renal dysfunction as a risk...
News
Redefining CVD risk: Cardiovascular-kidney-metabolic (CKM) syndrome
“Clearly defining the patient with CKM syndrome, and providing new approaches for CKM syndrome staging and risk prediction, will help health care...
Conference Coverage
SGLT2 inhibitors: No benefit or harm in hospitalized COVID-19
“I think the most important take-home message here is that the use of these medications appears to be safe even in really acutely ill hospitalized...